• This record comes from PubMed

Lower Limb Lymphedema Awareness among Gynecological Cancer Patients: An International Survey Supported by the European Network of Gynecological Cancer Advocacy Groups (ENGAGe) Group

. 2024 Apr 18 ; 16 (8) : . [epub] 20240418

Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic

Document type Journal Article

INTRODUCTION: Patient awareness of postoperative lymphedema in the field of gynecologic oncology has been poorly documented in the international literature. We wished to capture and document the awareness among gynecological cancer survivors about postoperative lymphedema, including aspects such as the adequacy of perioperative counseling, management, and quality of life. METHODS: A web-based survey comprising 25 multiple-choice questions was distributed to gynecological cancer advocacy groups within the European Network of Gynecological Cancer Advocacy Groups (ENGAGe) group. The survey was validated in a pilot group of gynecological patients prior to distribution. RESULTS: Overall, 386 women from 20 countries completed the questionnaire. Only half of the patients (n = 211) knew what lymphedema is, whereas 52% of the respondents stated that they were never informed at their pre-operative assessment about the potential risk of developing lymphedema. Fifty-three percent of those women who were informed about the risk and management of lymphedema received information through self-initiative, connecting mainly with patient groups or online. Approximately 84% of patients with lymphedema reported that they informed their doctor about their symptoms. Ninety-four patients (55.3%, which is not 55% of the 386) were treated for lymphedema. Forty-five women out of 136 reported that lymphedema significantly affected their everyday lives. DISCUSSION: We report a large lack of awareness and a significant gap of knowledge about the risks and treatment options related to postoperative lymphedema among gynecological cancer survivors. Institutional practice routines and awareness among professionals need to be urgently recalled and adapted to adequately inform and support gynecological cancer patients.

See more in PubMed

Keast D.H., Moffatt C., Janmohammad A. Lymphedema Impact and Prevalence International Study: The Canadian Data. Lymphat. Res. Biol. 2019;17:178–186. doi: 10.1089/lrb.2019.0014. PubMed DOI PMC

Huang J., Yu N., Wang X., Long X. Incidence of lower limb lymphedema after vulvar cancer: A systematic review and meta-analysis. Medicine. 2017;96:e8722. doi: 10.1097/MD.0000000000008722. PubMed DOI PMC

Yost K.J., Cheville A.L., Al-Hilli M.M., Mariani A., Barrette B.A., McGree M.E., Weaver A.L., Dowdy S.C. Lymphedema after surgery for endometrial cancer: Prevalence, risk factors, and quality of life. Obstet. Gynecol. 2014;124:307–315. doi: 10.1097/AOG.0000000000000372. PubMed DOI PMC

Bona A.F., Ferreira K.R., Carvalho R.B.M., Thuler L.C.S., Bergmann A. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: A systematic review. Int. J. Gynecol. Cancer. 2020;30:1697–1704. doi: 10.1136/ijgc-2020-001682. PubMed DOI

Harter P., Sehouli J., Lorusso D., Reuss A., Vergote I., Marth C., Kim J.-W., Raspagliesi F., Lampe B., Aletti G., et al. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms. N. Engl. J. Med. 2019;380:822–832. doi: 10.1056/NEJMoa1808424. PubMed DOI

Kuroda K., Yamamoto Y., Yanagisawa M., Kawata A., Akiba N., Suzuki K., Naritaka K. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: A hospital-based retrospective cohort study. BMC Women’s Health. 2017;17:50. doi: 10.1186/s12905-017-0403-1. PubMed DOI PMC

Todo Y., Yamamoto R., Minobe S., Suzuki Y., Takeshi U., Nakatani M., Aoyagi Y., Ohba Y., Okamoto K., Kato H. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol. Oncol. 2010;119:60–64. doi: 10.1016/j.ygyno.2010.06.018. PubMed DOI

Hayes S.C., Janda M., Ward L.C., Reul-Hirche H., Steele M.L., Carter J., Quinn M., Cornish B., Obermair A. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol. Oncol. 2017;146:623–629. doi: 10.1016/j.ygyno.2017.06.004. PubMed DOI

Iyigun Z.E., Duymaz T., Ilgun A.S., Alco G., Ordu C., Sarsenov D., Aydin A.E., Celebi F.E., Izci F., Eralp Y., et al. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer. Lymphat. Res. Biol. 2018;16:28–35. doi: 10.1089/lrb.2016.0045. PubMed DOI

Prodromidou A., Iavazzo C., Fotiou A., Psomiadou V., Drakou M., Vorgias G., Kalinoglou N. The application of fibrin sealant for the prevention of lymphocele after lymphadenectomy in patients with gynecological malignancies: A systematic review and meta-analysis of randomized controlled trials. Gynecol. Oncol. 2019;153:201–208. doi: 10.1016/j.ygyno.2019.01.011. PubMed DOI

Pergialiotis V., Kontzoglou K., Dimitroulis D., Vlachos D.E., Routsolias P., Vlachos G.D. Electrosurgical bipolar vessel sealing during axillary lymphadenectomy: A systematic review and meta-analysis. Breast Dis. 2015;35:5–11. doi: 10.3233/BD-140383. PubMed DOI

Ahmed R.L., Prizment A., Lazovich D., Schmitz K.H., Folsom A.R. Lymphedema and quality of life in breast cancer survivors: The Iowa Women’s Health Study. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2008;26:5689–5696. doi: 10.1200/JCO.2008.16.4731. PubMed DOI PMC

Carter J., Huang H.Q., Armer J., Carlson J.W., Lockwood S., Nolte S., Kauderer J., Hutson A., Walker J.L., Fleury A.C., et al. GOG 244-The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecol. Oncol. 2021;160:244–251. doi: 10.1016/j.ygyno.2020.10.023. PubMed DOI PMC

Koehler L., Penz L.E., John F., Stenzel A., Jewett P., Teoh D., Blaes A., Rivard C., Vogel R. Functional and psychosocial quality of life in gynecologic Cancer survivors with and without lymphedema symptoms. Gynecol. Oncol. 2023;170:254–258. doi: 10.1016/j.ygyno.2023.01.019. PubMed DOI PMC

Fu M.R., Axelrod D., Guth A.A., Cartwright F., Qiu Z., Goldberg J.D., Kim J., Scagliola J., Kleinman R., Haber J. Proactive approach to lymphedema risk reduction: A prospective study. Ann. Surg. Oncol. 2014;21:3481–3489. doi: 10.1245/s10434-014-3761-z. PubMed DOI PMC

Du X., Li Y., Fu L., Chen H., Zhang X., Shui Y., Zhang A., Feng X., Fu M.R. Strategies in activating lymphatic system to promote lymph flow on lymphedema symptoms in breast cancer survivors: A randomized controlled trial. Front. Oncol. 2022;12:1015387. doi: 10.3389/fonc.2022.1015387. PubMed DOI PMC

Lasinski B.B. Complete decongestive therapy for treatment of lymphedema. Semin. Oncol. Nurs. 2013;29:20–27. doi: 10.1016/j.soncn.2012.11.004. PubMed DOI

Kim S.I., Lim M.C., Lee J.S., Lee Y., Park K., Joo J., Seo S.-S., Kang S., Chung S.H., Park S.-Y. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015;192:31–36. doi: 10.1016/j.ejogrb.2015.06.011. PubMed DOI

Cemal Y., Jewell S., Albornoz C.R., Pusic A., Mehrara B.J. Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema. Lymphat. Res. Biol. 2013;11:14–19. doi: 10.1089/lrb.2012.0015. PubMed DOI PMC

Krzywonos A., Ochałek K., Krzywonos-Zawadzka A., Pitala K. Assessment of knowledge of cancer and lymphoedema among breast cancer survivors. Menopause Rev. Przegląd Menopauzalny. 2014;13:273–279. doi: 10.5114/pm.2014.45170. PubMed DOI PMC

Pervane Vural S., Ayhan F.F., Soran A. The Role of Patient Awareness and Knowledge in Developing Secondary Lymphedema after Breast and Gynecologic Cancer Surgery. Lymphat. Res. Biol. 2020;18:526–533. doi: 10.1089/lrb.2020.0059. PubMed DOI

Choi J.K., Kim H.D., Sim Y.J., Kim G.C., Kim D.K., Yu B.C., Park S.S., Jeong H.J. A Survey of the Status of Awareness of Lymphedema in Breast Cancer Patients in Busan-Gyeongnam, Korea. Ann. Rehabil. Med. 2015;39:609–615. doi: 10.5535/arm.2015.39.4.609. PubMed DOI PMC

Borman P., Yaman A., Yasrebi S., Özdemir O. The Importance of Awareness and Education in Patients with Breast Cancer-Related Lymphedema. J. Cancer Educ. 2017;32:629–633. doi: 10.1007/s13187-016-1026-1. PubMed DOI

Bosompra K., Ashikaga T., O’Brien P.J., Nelson L., Skelly J., Beatty D.J. Knowledge about preventing and managing lymphedema: A survey of recently diagnosed and treated breast cancer patients. Patient Educ. Couns. 2002;47:155–163. doi: 10.1016/S0738-3991(01)00193-8. PubMed DOI

Fu M.R., Chen C.M., Haber J., Guth A.A., Axelrod D. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors. Ann. Surg. Oncol. 2010;17:1847–1853. doi: 10.1245/s10434-010-0941-3. PubMed DOI

Ostby P.L., Armer J.M., Smith K., Stewart B.R. Patient Perceptions of Barriers to Self-Management of Breast Cancer-Related Lymphedema. West. J. Nurs. Res. 2018;40:1800–1817. doi: 10.1177/0193945917744351. PubMed DOI PMC

Armbrust R., Auletta V., Cichon G., Vercellino G., Yost K., Sehouli J. Lymphedema after pelvic and para-aortic lymphadenectomy—Results of a systematic evaluation in patients with cervical and endometrial carcinoma. Arch. Gynecol. Obstet. 2023;307:1557–1565. doi: 10.1007/s00404-022-06779-8. PubMed DOI PMC

Winters H., Tielemans H.J.P., Paulus V., Hummelink S., Slater N.J., Ulrich D.J.O. A systematic review and meta-analysis of vascularized lymph node transfer for breast cancer-related lymphedema. J. Vasc. Surg. Venous Lymphat. Disord. 2022;10:786–795.e781. doi: 10.1016/j.jvsv.2021.08.023. PubMed DOI

Chang E.I., Skoracki R.J., Chang D.W. Lymphovenous Anastomosis Bypass Surgery. Semin. Plast. Surg. 2018;32:22–27. doi: 10.1055/s-0038-1636510. PubMed DOI PMC

Smoot B., Chiavola-Larson L., Lee J., Manibusan H., Allen D.D. Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: A systematic review and meta-analysis. J. Cancer Surviv. 2015;9:287–304. doi: 10.1007/s11764-014-0411-1. PubMed DOI

Fu M.R., Ridner S.H., Hu S.H., Stewart B.R., Cormier J.N., Armer J.M. Psychosocial impact of lymphedema: A systematic review of literature from 2004 to 2011. Psychooncology. 2013;22:1466–1484. doi: 10.1002/pon.3201. PubMed DOI PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...